Search Results - "Bugaj, L. J."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway by Bugaj, L J, Sabnis, A J, Mitchell, A, Garbarino, J E, Toettcher, J E, Bivona, T G, Lim, W A

    “…The Ras-Erk (extracellular signal-regulated kinase) pathway encodes information in its dynamics; the duration and frequency of Erk activity can specify…”
    Get full text
    Journal Article
  2. 2

    Regulation of endogenous transmembrane receptors through optogenetic Cry2 clustering by Bugaj, L. J., Spelke, D. P., Mesuda, C. K., Varedi, M., Kane, R. S., Schaffer, D. V.

    Published in Nature communications (22-04-2015)
    “…Transmembrane receptors are the predominant conduit through which cells sense and transduce extracellular information into intracellular biochemical signals…”
    Get full text
    Journal Article
  3. 3
  4. 4

    [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients by Kwekkeboom, D J, Bakker, W H, Kooij, P P, Konijnenberg, M W, Srinivasan, A, Erion, J L, Schmidt, M A, Bugaj, J L, de Jong, M, Krenning, E P

    Published in European Journal of Nuclear Medicine (01-09-2001)
    “…The somatostatin analogue [DOTA0,Tyr3]octreotate has a nine-fold higher affinity for the somatostatin receptor subtype 2 as compared with [DOTA0,…”
    Get full text
    Journal Article
  5. 5